Ondansetron 2Mg/Ml (Syrup)

Price 2 INR/ Bottle

Get a Price/Quote

MOQ : 100 Bottles

Ondansetron 2Mg/Ml (Syrup) Specification

Pacakaging (Quantity Per Box)
30 Ml

Indication
Used for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery.

Salt Composition
Ondansetron

Origin of Medicine
Manufactured in India in accordance with pharmaceutical quality standards.

Dosage Form
Syrup

Ingredients
Ondansetron

Physical Form
Liquid

Function
Other

Recommended For
As directed by physician

Dosage
As directed by physician

Dosage Guidelines
As directed by physician

Suitable For
Suitable For All

Quantity
100 Pieces

Storage Instructions
Store in a cool and dry place

Remote Battery Type
AAA

Operating System
Android

Viewing Angle
178

Sleep Timer
Yes

Smart TV Features
Built-in WiFi, Screen Mirroring

Refresh Rate
60 Hz

USB Ports
2

Ondansetron 2Mg/Ml (Syrup) Trade Information

Minimum Order Quantity
100 Bottles

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
30 Ml

Main Export Market(s)
Asia

Main Domestic Market
All India

About Ondansetron 2Mg/Ml (Syrup)

Spotlight your healthcare offering with Supreme Ondansetron 2Mg/Ml Syrup, an immaculate solution forged in India for first-class prevention of nausea and vomiting. Utilise and access this trusted liquid formula-comprising the main ingredient Ondansetron-specifically engineered for optimal results post-chemotherapy, radiation, or surgery. Each 30 ml bottle, packed in boxes of 100 pieces, assures consistency and quality. Offer patients an advanced option stored in a cool, dry location. Suitable for all ages, this syrup upholds first-class pharmaceutical standards for safe, recommended use as prescribed by registered physicians.

Key Applications and Distinct Advantages

Ondansetron 2Mg/Ml Syrup is primarily used for the prevention and treatment of nausea and vomiting linked with chemotherapy, radiation therapy, and postoperative recovery. Its area of application extends to hospitals, clinics, and home care settings. This product's competitive advantages stem from its supreme formulation, impeccable safety profile, and the trust it inspires in healthcare professionals and patients alike. Its first-class quality ensures consistent efficacy and rapid relief, making it a preferred choice for antiemetic therapy.

Domestic Market Presence and Logistics

Our Ondansetron Syrup enjoys strong market value across India's main domestic markets, with stock ready for prompt handover. As a manufacturer, supplier, and trader, we maintain a robust supply ability to meet varying medical demands efficiently. Payment terms are designed to be flexible, supporting both bulk orders and recurring procurement. The product's reliability and stringently controlled storage reinforce its strong reputation, ensuring healthcare providers can depend on timely availability for their patients.

FAQ's of Ondansetron 2Mg/Ml (Syrup):

Q: How should Ondansetron 2Mg/Ml Syrup be administered?

A: Ondansetron Syrup should be taken according to your physician's directions, typically before or after chemotherapy, radiation treatments, or surgery, to prevent nausea and vomiting.

Q: What are the benefits of choosing this specific Ondansetron formulation?

A: This syrup offers a first-class, meticulously manufactured composition that ensures consistent dosage and rapid relief, suitable for all age groups and trusted by healthcare professionals.

Q: When is the best time to use Ondansetron 2Mg/Ml Syrup?

A: The syrup should be used as prescribed by a physician, often just prior to and following cancer treatments or surgery to maintain optimal effectiveness in preventing nausea and vomiting.

Q: Where is Ondansetron 2Mg/Ml Syrup manufactured and how is quality assured?

A: This product is manufactured in India, adhering strictly to supreme pharmaceutical quality standards, ensuring an immaculate and dependable medication for medical professionals and patients.